MaxCyte (MXCT) 2025 Earnings Outlook for Investors
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
Ways To Align Spending With Financial Goals
Learn ways to align every expenditure with your financial goals. Prioritize essential spending, reduce waste, and monitor goal progress.
23,330 articlesStock Sells 87,000 Shares: IHS Stock Up 57% Sparks Investor Questions
IHS stock is up 57% as insiders trade. A CEO sale of 87,000 shares sparks questions about momentum and governance. Th...
Cowen Raises Strategy Price Target to $395 on BTC Yield
TD Cowen raises its Strategy price target to 395, driven by a shift toward STRC issuance and an improved BTC yield ou...
Hacker Drains $5.9M From Ethereum Liquidity TrustedVolumes
A security flaw allowed a hacker to drain approximately $5.9 million from TrustedVolumes, a DeFi liquidity provider o...
BTC Recovers From CPI-Induced Dip as Markets Stabilize
Bitcoin rebounds after inflation data sparked a dip, reclaiming key support as altcoins swing. A viral meme token tum...
Palantir’s Forged Connection with Investors via Letters
Palantir’s CEO has shifted away from traditional earnings calls, instead sending quarterly shareholder letters that m...
Rocket Lab vs SpaceX: Which Stock Is the Best Aerospace Buy
Investors are eyeing space stocks, but SpaceX remains private while Rocket Lab trades on the public market. This guid...
Renew (rnw) 2026 Earnings: Outlook & Investment Guide
Renew (rnw) just released its 2026 earnings, signaling momentum in project execution and cash flow. This article brea...
Target Corp After Latest Earnings: Is It a Buy Now?
Target Corp after latest earnings has investors weighing risk and reward. This guide breaks down what the numbers mea...
Why Poet Technologies Stock Plummeted This Week Explained
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
Synopsys Growth Trap Risk for Investor Portfolios in 2026
As markets digest AI hype, Synopsys faces a potential growth trap: strong licensing revenue amid squeezed margins and...
CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status